10th Anniversary Symposium

Susan Ragon (left) and Terry Ragon (right) signing the endowment agreement

Through the incredible generosity of Terry and Susan Ragon, the Ragon Institute was established in 2009, creating a new model for life-saving scientific discovery and innovation. In 2019, at the 10th anniversary of the Institute, the Philip T. and Susan M. Ragon Foundation reaffirmed its commitment with a new $278 million endowment. The foundation is further funding the construction of a new building for the institute on MIT’s campus.


Director Bruce Walker giving a toast during the 10th Anniversary Celebration

By providing flexible funding not otherwise available to promote cross-disciplinary collaborations, new ideas are hatched and move forward with greatest possible speed. Ten years after its founding, the Ragon Institute has a promising HIV vaccine candidate being tested in humans—a vaccine that has shown substantial protection in animal models—and is extending its model to new goals including tuberculosis, influenza and other global threats.


From left to right: L. Rafael Raif, President of MIT; Peter Slavin, President of MGH; Terry and Susan Ragon; Bruce Walker, Director; Drew Gilpin Faust, President Emerita of Harvard University; Facundo Batista, Associate Director


The Institute’s endowment ensures that its transformative impact on human health continues long into the future. “Although MGH, MIT and Harvard are wealthy institutions, Susan and I had no idea how important our philanthropy could be, using this fulcrum of talented investigators to leverage medical advances that would not otherwise be possible,” said Terry Ragon. “The first decade has been exhilarating, and we can’t wait to see the advances that are yet to come.”